Kane Biotech Inc. KNE.V
Health Care · Pharmaceuticals, Biotechnology & Life Sciences · TSX-V · Canada · kanebiotech.com
Kane Biotech Inc. is a biotechnology company engaged in the research, development, and commercialization of technologies and products designed to prevent and remove microbial biofilms. The company's product portfolio includes wound care and surgical hydrogel products marketed under the revyve and coactiv+ brands, leveraging its proprietary DispersinB enzyme platform. Kane Biotech is headquartered in Winnipeg, Manitoba, Canada.
Key ratios
FreeCashFlowOnSale TTM -44.85
FreeCashFlowOnSale 2025 -7.62
FreeCashFlowOnSale 2024 -1.99
FreeCashFlowOnSale 2023 -14.04
NetIncomeMargin TTM -1.8
NetIncomeMargin 2024 2.93
ReturnOnAssets TTM -0.58
ReturnOnAssets 2025 -0.62
ReturnOnAssets 2024 -0.57
ReturnOnAssets 2023 -0.37
TotalRevenueYoYGrowth TTM -0.98
TotalRevenueYoYGrowth 2025 -0.79
TotalRevenueYoYGrowth 2024 12.97
TotalRevenueYoYGrowth 2023 -0.05
Recent news
Kane Biotech Announces Results of Annual and Special Meeting of Shareholders
2026-07-02 · GlobeNewswire
Kane Biotech Announces First Quarter 2026 Financial Results
2026-05-28 · GlobeNewswire
Kane Biotech Restarts Commercial Activities and Strengthens North American Management
2026-02-12 · BioSpace